vs
Alpha Metallurgical Resources, Inc.（AMR）与Ascendis Pharma A/S（ASND）财务数据对比。点击上方公司名可切换其他公司
Alpha Metallurgical Resources, Inc.的季度营收约是Ascendis Pharma A/S的1.9倍（$519.1M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs -15.7%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs -22.4%）
阿尔法冶金资源（前身为康图拉能源）是行业领先的煤炭供应商，在阿巴拉契亚北部和中部拥有地下及露天煤矿综合体，在宾夕法尼亚州、弗吉尼亚州和西弗吉尼亚州坐拥大型煤田，生产用于炼钢的冶金煤和用于发电的动力煤，供应全球下游客户。
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
AMR vs ASND — 直观对比
营收规模更大
AMR
是对方的1.9倍
$267.3M
营收增速更快
ASND
高出58.0%
-15.7%
两年增速更快
ASND
近两年复合增速
-22.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $519.1M | $267.3M |
| 净利润 | $-17.3M | — |
| 毛利率 | — | 90.5% |
| 营业利润率 | -4.1% | — |
| 净利率 | -3.3% | — |
| 营收同比 | -15.7% | 42.3% |
| 净利润同比 | -711.2% | — |
| 每股收益（稀释后） | $-1.35 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRASND
| Q4 25 | $519.1M | $267.3M | ||
| Q3 25 | $525.2M | $230.7M | ||
| Q2 25 | $548.7M | $170.7M | ||
| Q1 25 | $529.7M | $109.0M | ||
| Q4 24 | $615.4M | $187.8M | ||
| Q3 24 | $669.8M | $62.5M | ||
| Q2 24 | $800.1M | $38.9M | ||
| Q1 24 | $861.3M | $103.6M |
净利润AMRASND
| Q4 25 | $-17.3M | — | ||
| Q3 25 | $-5.5M | $-65.9M | ||
| Q2 25 | $-5.0M | $-42.0M | ||
| Q1 25 | $-33.9M | $-102.2M | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $3.8M | $-107.1M | ||
| Q2 24 | $58.9M | $-118.1M | ||
| Q1 24 | $127.0M | $-141.5M |
毛利率AMRASND
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 89.5% | ||
| Q2 25 | — | 80.1% | ||
| Q1 25 | — | 82.6% | ||
| Q4 24 | — | 91.9% | ||
| Q3 24 | — | 80.6% | ||
| Q2 24 | — | 68.2% | ||
| Q1 24 | — | 92.1% |
营业利润率AMRASND
| Q4 25 | -4.1% | — | ||
| Q3 25 | -0.5% | 5.1% | ||
| Q2 25 | 0.5% | -33.5% | ||
| Q1 25 | -7.6% | -103.2% | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 0.8% | -167.3% | ||
| Q2 24 | 8.8% | -370.2% | ||
| Q1 24 | 16.5% | -51.2% |
净利率AMRASND
| Q4 25 | -3.3% | — | ||
| Q3 25 | -1.1% | -28.5% | ||
| Q2 25 | -0.9% | -24.6% | ||
| Q1 25 | -6.4% | -93.7% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 0.6% | -171.5% | ||
| Q2 24 | 7.4% | -303.9% | ||
| Q1 24 | 14.7% | -136.6% |
每股收益（稀释后）AMRASND
| Q4 25 | $-1.35 | — | ||
| Q3 25 | $-0.42 | — | ||
| Q2 25 | $-0.38 | — | ||
| Q1 25 | $-2.60 | — | ||
| Q4 24 | $-0.09 | — | ||
| Q3 24 | $0.29 | — | ||
| Q2 24 | $4.49 | — | ||
| Q1 24 | $9.59 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $415.6M | $665.3M |
| 总债务越低越好 | $9.8M | — |
| 股东权益账面价值 | $1.5B | $-175.8M |
| 总资产 | $2.3B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资AMRASND
| Q4 25 | $415.6M | $665.3M | ||
| Q3 25 | $457.9M | $582.2M | ||
| Q2 25 | $449.0M | $533.6M | ||
| Q1 25 | $448.0M | $559.4M | ||
| Q4 24 | $481.6M | $604.3M | ||
| Q3 24 | $484.6M | $675.6M | ||
| Q2 24 | $336.1M | $279.4M | ||
| Q1 24 | $269.4M | $345.9M |
总债务AMRASND
| Q4 25 | $9.8M | — | ||
| Q3 25 | $2.9M | — | ||
| Q2 25 | $3.1M | — | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $3.6M | — | ||
| Q2 24 | $5.3M | — | ||
| Q1 24 | $6.0M | — |
股东权益AMRASND
| Q4 25 | $1.5B | $-175.8M | ||
| Q3 25 | $1.6B | $-188.0M | ||
| Q2 25 | $1.6B | $-202.6M | ||
| Q1 25 | $1.6B | $-205.0M | ||
| Q4 24 | $1.6B | $-114.2M | ||
| Q3 24 | $1.7B | $-105.1M | ||
| Q2 24 | $1.6B | $-346.8M | ||
| Q1 24 | $1.6B | $-257.2M |
总资产AMRASND
| Q4 25 | $2.3B | $1.4B | ||
| Q3 25 | $2.3B | $1.2B | ||
| Q2 25 | $2.4B | $1.2B | ||
| Q1 25 | $2.4B | $1.1B | ||
| Q4 24 | $2.4B | $1.3B | ||
| Q3 24 | $2.5B | $1.2B | ||
| Q2 24 | $2.5B | $819.0M | ||
| Q1 24 | $2.5B | $866.7M |
负债/权益比AMRASND
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.0M | $58.2M |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | — |
| 自由现金流率自由现金流/营收 | -1.9% | — |
| 资本支出强度资本支出/营收 | 5.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $17.8M | — |
8季度趋势，按日历期对齐
经营现金流AMRASND
| Q4 25 | $19.0M | $58.2M | ||
| Q3 25 | $50.5M | — | ||
| Q2 25 | $53.2M | — | ||
| Q1 25 | $22.2M | $-15.5M | ||
| Q4 24 | $56.3M | $-330.7M | ||
| Q3 24 | $189.5M | — | ||
| Q2 24 | $138.1M | — | ||
| Q1 24 | $196.1M | $-109.7M |
自由现金流AMRASND
| Q4 25 | $-10.0M | — | ||
| Q3 25 | $25.4M | — | ||
| Q2 25 | $18.6M | — | ||
| Q1 25 | $-16.3M | — | ||
| Q4 24 | $13.6M | — | ||
| Q3 24 | $158.0M | — | ||
| Q2 24 | $77.0M | — | ||
| Q1 24 | $132.5M | — |
自由现金流率AMRASND
| Q4 25 | -1.9% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | -3.1% | — | ||
| Q4 24 | 2.2% | — | ||
| Q3 24 | 23.6% | — | ||
| Q2 24 | 9.6% | — | ||
| Q1 24 | 15.4% | — |
资本支出强度AMRASND
| Q4 25 | 5.6% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 7.3% | — | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 7.6% | — | ||
| Q1 24 | 7.4% | — |
现金转化率AMRASND
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 49.81× | — | ||
| Q2 24 | 2.34× | — | ||
| Q1 24 | 1.54× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
